BLOOD CANCER DISCOV 润色咨询

BLOOD CANCER DISCOVERY

出版年份：暂无数据 年文章数：70 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1218353, encodeId=abed121835338, content=审稿速度:2.0<br>偏重的研究方向：骨髓瘤;CarT;临床<br>经验分享：秒拒，虽然没有IF，但感觉很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=Genius, createdTime=Tue May 10 08:35:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216784, encodeId=88cf1216e84f7, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：转化;淋巴瘤;CarT<br>经验分享：虽然没有IF，但难度较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=123b79d2m38(暂无昵称), createdTime=Wed May 04 14:46:04 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216783, encodeId=54941216e83cb, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：秒拒，可能对标CD的质量吧，我想应该比Blood要高一个档次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=123b79d2m38(暂无昵称), createdTime=Wed May 04 14:44:16 CST 2022, time=2022-05-04, status=1, ipAttribution=)]
    2022-05-10 Genius

    审稿速度:2.0
    偏重的研究方向：骨髓瘤;CarT;临床
    经验分享：秒拒，虽然没有IF，但感觉很难投

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1218353, encodeId=abed121835338, content=审稿速度:2.0<br>偏重的研究方向：骨髓瘤;CarT;临床<br>经验分享：秒拒，虽然没有IF，但感觉很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=Genius, createdTime=Tue May 10 08:35:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216784, encodeId=88cf1216e84f7, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：转化;淋巴瘤;CarT<br>经验分享：虽然没有IF，但难度较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=123b79d2m38(暂无昵称), createdTime=Wed May 04 14:46:04 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216783, encodeId=54941216e83cb, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：秒拒，可能对标CD的质量吧，我想应该比Blood要高一个档次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=123b79d2m38(暂无昵称), createdTime=Wed May 04 14:44:16 CST 2022, time=2022-05-04, status=1, ipAttribution=)]
    2022-05-04 123b79d2m38(暂无昵称)

    审稿速度:2.0 | 投稿命中率:5.0
    偏重的研究方向：转化;淋巴瘤;CarT
    经验分享：虽然没有IF，但难度较高。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218353, encodeId=abed121835338, content=审稿速度:2.0<br>偏重的研究方向：骨髓瘤;CarT;临床<br>经验分享：秒拒，虽然没有IF，但感觉很难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=Genius, createdTime=Tue May 10 08:35:36 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216784, encodeId=88cf1216e84f7, content=审稿速度:2.0 | 投稿命中率:5.0<br>偏重的研究方向：转化;淋巴瘤;CarT<br>经验分享：虽然没有IF，但难度较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=123b79d2m38(暂无昵称), createdTime=Wed May 04 14:46:04 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216783, encodeId=54941216e83cb, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：秒拒，可能对标CD的质量吧，我想应该比Blood要高一个档次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220506/390e3db992e54051876ea8f2b93fdfc3/8b383d5bed0342e7908a61cdfe500fcb.jpg, createdBy=64682431106, createdName=123b79d2m38(暂无昵称), createdTime=Wed May 04 14:44:16 CST 2022, time=2022-05-04, status=1, ipAttribution=)]
    2022-05-04 123b79d2m38(暂无昵称)

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：秒拒，可能对标CD的质量吧，我想应该比Blood要高一个档次。

    0

共3条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分